Contributors


NEIL CANAVAN

Latest:

'A Cure Within'

A new book delves into the stories of 25 immunotherapy pioneers and the history of the field they helped to develop.


PCRI

Latest:

2016 Prostate Cancer Conference

"The Prostate Cancer Research Institute, (PCRI), a 501(c)(3) not-for-profit organization, mission is to improve the quality of prostate cancer patients and caregivers lives by supporting research and disseminating information that educates and empowers patients, families and the medical community."


Frank A. Vicini, MD

Latest:

Is Radiation Therapy in Early-Stage Breast Cancer Always Necessary?

Women diagnosed with early-stage breast cancer have a variety of decisions to make regarding treatment, but it's important for patients to realize all of their options when making those medical decisions.


Luke Peppone

Latest:

The Surprising Benefit of Soybean Oil for Patients With Breast Cancer

Luke Peppone, assistant professor at the University of Rochester Medical Center, discusses the surprising benefits soybean oil had for patients with breast cancer.


Don Henry

Latest:

Antiperspirant Use OK for Women Getting Breast Radiation

Changes could lessen women's worries about body odor.


Paula Vincent, RN, CNM

Latest:

Why She Matters So Much

I hold tight to the belief that I am a survivor who is living with, not dying from, metastatic breast cancer.


Connie J. Trotter

Latest:

I Thought My Oncology Nurse Was an Angel

An Extraordinary Healer essay honoring BROOKE DAVIS, RN [ONCOLOGY SPECIALISTS OF CHARLOTTE, NORTH CAROLINA]


Eric Nadler, MD

Latest:

The Complexities of Genetic Testing

The progress made in genetic testing for breast cancer.





Jessica Bembry, RN, BSN, OCN

Latest:

A Healer for the Heart and Soul Throughout My Cancer Journey

An Extraordinary Healer essay honoring Shirley Davis, RN, OCN [Wellmont Health System in Tennessee]



Michelle Esser

Latest:

Michelle Esser Discusses Two Encouraging Breast Cancer Studies

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).


Paul J. Weber

Latest:

Pet Project

The benefits of pet-patient interaction suggest it's more than "alternative therapy."


Santosh Kesari

Latest:

Santosh Kesari on Thinking Outside the Box in GBM Research

Santosh Kesari discusses the need to think outside the box when conducting research in glioblastoma multiforme (GBM).


Marlee Matlin

Latest:

Marlee Matlin Discusses Her Father's Diagnosis of Multiple Myeloma

Marlee Matlin, an Academy award-winning actress, discusses her father’s diagnosis and journey with multiple myeloma.


Phylis McKiernan, APN, MSN, OCN

Latest:

Recognizing Side Effects in Novel Treatments for CLL Can Be Crucial

Patients taking novel treatments for CLL, and their caregivers, should know which side effects to expect — and recognize when they become emergencies.


Ronny Allan

Latest:

Poker Face or Cancer Card?

Before I was diagnosed, I had my share of illnesses, but none that slowed me down like cancer could.


Jennifer L. W. Fink, RN

Latest:

When Someone You Love Has Brain Cancer

When caring for someone who has undergone brain surgery, practice patience and ask for support.


John C. Byrd, M.D.

Latest:

Cure: Is it Possible for CLL?

Will the word "cure" be used for patients with chronic lymphocytic leukemia (CLL)?


David O'Malley, M.D.

Latest:

Exploring Another Biomarker in Ovarian Cancer

Folate receptor alpha was a promising biomarker when it came to treatment with mirvetuximab soravtansine.


Padmanee Sharma, M.D., Ph.D.

Latest:

There Are Multiple Dynamic Biomarkers for Bladder Cancer

While there are a few common and well-known checkpoints for bladder cancer, there are also many more than PD-1, PD-L1 and CTLA-4.


Dr. Javier Cortes

Latest:

Keytruda Plus Chemotherapy Improves Survival Outcome in Metastatic Triple-Negative Breast Cancer

First-line treatment with Keytruda (pembrolizumab) in combination with chemotherapy improves progression-free survival in patients with locally recurrent, inoperable or metastatic triple-negative breast cancer (mTNBC), according to data presented at the 2020 ASCO Virtual Scientific Program.


Lovell Jones

Latest:

Prevention in America

Enhancing cancer prevention efforts in minority communities


Rick Boulay, M.D.

Latest:

Cancer, Redefined: Personalized Medicine

What if there were some way to identify gene mutations causing the cell to behave as a cancer and then, with a medication, undo the effects of the errant gene? This is the basis of personalized medicine.


Andrea Wilson Woods

Latest:

Committed to Change: Blue Faery's Fight Against Liver Cancer

After losing the sister she raised to an aggressive type of liver cancer, one woman has devoted herself to stamping out the disease.


Holly DeFeo, M.S.N., RN-BC

Latest:

The Essence of a Leader

This essay nominating oncology certified registered nurse, Abbi Bruce, for the 2019 CURE® Extraordinary Healer® Award, was written by her colleague, Holly DeFeo, a board certified registered nurse at Hartford HealthCare Cancer Institute.


Mike Hennessy Sr., Chairman

Latest:

The Power of Human Connection in Cancer

Now that things are slowly getting back to normal as more people become vaccinated, we welcome back the idea with open arms of in-person connections. But there’s still one population that needs more human connection: those with a rare cancer.


Mary Bohn

Latest:

Mary Bohn on the Landscape of Multiple Myeloma Treatment

Mary Bohn, RN, OCN, a nurse at Froedtert Hospital in Milwaukee, Wisconsin, discusses the landscape and side effects of treatment for patients with multiple myeloma.